Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV001169990 | SCV001251806 | uncertain significance | Schwartz-Jampel syndrome | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001361626 | SCV001557605 | uncertain significance | not provided | 2022-04-30 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 2212 of the HSPG2 protein (p.Asp2212Asn). This variant is present in population databases (rs780545355, gnomAD 0.01%). This missense change has been observed in individual(s) with intellectual disability (PMID: 29302074). ClinVar contains an entry for this variant (Variation ID: 915381). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001361626 | SCV001990715 | uncertain significance | not provided | 2020-03-24 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29302074) |